SOCIETAL CDMO, INC. Financial Statements (2024 and earlier)

Company Profile

Business Address 1 E. UWCHLAN AVE, SUITE 112
EXTON, PA 19341
State of Incorp. PA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments8,1564,7036,29314,99511,57715,481
Cash and cash equivalents8,1564,7036,29314,99511,57715,481
Receivables14,77115,52215,22915,95017,10416,524
Inventory, net of allowances, customer advances and progress billings12,27912,85911,57410,3019,4148,366
Inventory12,27912,85911,57410,3019,4148,366
Contract with customer, asset, after allowance for credit loss10,0767,7478,6048,7249,4129,359
Disposal group, including discontinued operation2,8152,8022,8012,768  
Other undisclosed current assets1,6882,9883,3372,8481,9872,245
Total current assets:49,78546,62147,83855,58649,49451,975
Noncurrent Assets
Operating lease, right-of-use asset5,1325,2545,3725,4915,6045,712
Property, plant and equipment51,13251,21250,85750,36549,02250,957
Intangible assets, net (including goodwill)43,48543,65343,82144,00544,22544,469
Goodwill41,07741,07741,07741,07741,07741,077
Intangible assets, net (excluding goodwill)2,4082,5762,7442,9283,1483,392
Other undisclosed noncurrent assets1,9961,9962,0501,9962,934246
Total noncurrent assets:101,745102,115102,100101,857101,785101,384
TOTAL ASSETS:151,530148,736149,938157,443151,279153,359
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10,63311,06610,60514,1526,8016,149
Interest and dividends payable32323
Employee-related liabilities3,7123,490
Accounts payable2,1243,9292,3921,4663,0572,336
Accrued liabilities8,5097,1378,21312,686  
Debt9,8917,1487,8407,577  
Due to related parties 2,0392,039
Other undisclosed current liabilities1,0991,0931,0861,0795,3405,040
Total current liabilities:21,62319,30719,53122,80814,18013,228
Noncurrent Liabilities
Long-term debt and lease obligation27,44431,01030,46230,967100,15699,129
Long-term debt, excluding current maturities27,44431,01030,46230,96795,47894,360
Liabilities, other than long-term debt6,0206,1316,2326,3341,6393,586
Deferred revenue      
Lease deposit liability1,7501,7501,7501,750  
Due to related parties 1,6393,586
Operating lease, liability4,2704,3814,4824,5844,6784,769
Other undisclosed noncurrent liabilities38,18637,97037,73737,4757087
Total noncurrent liabilities:71,65075,11174,43174,776101,865102,802
Total liabilities:93,27394,41893,96297,584116,045116,030
Equity
Equity, attributable to parent58,25754,31855,97659,85935,23437,329
Preferred stock   4,3324,350  
Common stock1,048900849846567566
Additional paid in capital335,332326,949321,114320,298291,133289,900
Accumulated deficit(278,123)(273,531)(270,319)(265,635)(256,466)(253,137)
Total equity:58,25754,31855,97659,85935,23437,329
TOTAL LIABILITIES AND EQUITY:151,530148,736149,938157,443151,279153,359

Income Statement (P&L) ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Revenues23,59021,79921,52724,27921,58923,152
Cost of revenue
(Cost of Goods and Services Sold)
(19,870)(17,327)(19,279)(17,437)(16,055)(17,470)
Gross profit:3,7204,4722,2486,8425,5345,682
Operating expenses(5,477)(5,440)(4,846)(6,229)(5,319)(5,380)
Operating income (loss):(1,757)(968)(2,598)613215302
Nonoperating income79109131   
Interest and debt expense(2,911)(2,314)(2,145)(8,677)(3,544)(3,421)
Loss from continuing operations before income taxes:(4,589)(3,173)(4,612)(8,064)(3,329)(3,119)
Income tax expense(3)(39)(72)   
Other undisclosed loss from continuing operations    (1,105)  
Loss from continuing operations:(4,592)(3,212)(4,684)(9,169)(3,329)(3,119)
Loss before gain (loss) on sale of properties:(3,329)(3,119)
Net loss available to common stockholders, diluted:(4,592)(3,212)(4,684)(9,169)(3,329)(3,119)

Comprehensive Income ($ in thousands)

12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
Net loss:(4,592)(3,212)(4,684)(9,169)(3,329)(3,119)
Comprehensive loss, net of tax, attributable to parent:(4,592)(3,212)(4,684)(9,169)(3,329)(3,119)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: